When I was diagnosed with relapsing-remitting multiple sclerosis (MS) at 16, it was loud. My symptoms were significant; the fatigue ended my athletic drive, the searing nerve pain left me grinding my teeth constantly, and I experienced a period of being legally blind. MS didn’t politely…
Following specific diets may help reduce inflammation in people with multiple sclerosis (MS), but more research is needed, according to a new review paper. Researchers analyzed data from 13 randomized clinical trials and found some evidence that certain diets, including modified Mediterranean-style and Paleolithic diets, were linked to…
A type of immune cell that has received little attention in multiple sclerosis (MS) research may play a key role in driving the disease. A study found that some people with MS had abnormally high levels of virus-fighting CD8 T-cells in the fluid surrounding the brain and spinal cord.
A clinical trial testing TG Therapeutics‘ CD20 inhibitor Briumvi (ublituximab-xiiy) in children with relapsing forms of multiple sclerosis (MS) will begin enrolling participants within the next few months, the developer announced, also unveiling details of the study’s design. The upcoming Phase 2/3 trial (NCT07220252) will run…
Discussion
It took exactly 14 days for my health insurance to pick the first fight with me this year. The letter arrived quietly, the way these things always do. Denied. Out of network. This time it was Octave Bioscience’s Multiple Sclerosis Disease Activity (MSDA) test, a blood test that evaluates…
Get regular updates to your inbox.
